A rapid response of lung squamous cell carcinoma following treatment with sintilimab combined with recombinant humane endostatin injection and nab-paclitaxel in an elderly patient: A case report

RATIONALE: At present, the prognosis of patients with giant lung squamous cell carcinoma (LSCC) is poor, and there is no safe and effective treatment for elderly patients with large LSCC. PATIENT CONCERNS: Here, we reported a 77-year-old man admitted to the hospital with cough for 3 months and signi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yueyu, Sun, Hui, Chen, Yi, Jiang, Nanyuan, Ji, Lianhua, Shi, Junfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341334/
https://www.ncbi.nlm.nih.gov/pubmed/34397833
http://dx.doi.org/10.1097/MD.0000000000026801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341334/
https://www.ncbi.nlm.nih.gov/pubmed/34397833
http://dx.doi.org/10.1097/MD.0000000000026801

Ejemplares similares